| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.008 |